Retraction
Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
Paper Information
Record ID:
50503
Journal:
Publication Date:
February 09, 2021
Retraction Date:
December 07, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Frontiers
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations1
Post-Retraction(7.7%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
55
Days since retraction (latest)
Polymer lipid hybrid nanoparticles encapsulated with Emodin combined with DOX reverse multidrug resistance of breast cancer via IL-6/JAK2/STAT3 signaling pathway
Honghui Gu, Fansu Meng, Haidong Sun et al. (9 authors)
Cancer Nanotechnology
Open Access
Published: Jan 2024
4 citations
4 citations
55 days after retraction
Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer
Estera Okoń, Katarzyna Gaweł‐Bęben, Agata Jarząb et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Oct 2023
4 citations
4 citations
37 days before retraction
Anticancer action of naturally occurring emodin for the controlling of cervical cancer
Priyanka S. Lande, Vaibhav S. Adhao, Jaya P. Ambhore et al. (6 authors)
Exploration of Targeted Anti-tumor Therapy
Open Access
Published: Aug 2023
2 citations
2 citations
98 days before retraction
Systems biology based miRNA–mRNA expression pattern analysis of Emodin in breast cancer cell lines
Elif Sakalli-Tecim, Bala Gür Dedeoğlu, Tülïn Güray
Pathology - Research and Practice
Published: Aug 2023
3 citations
3 citations
107 days before retraction
Polymer lipid hybrid nanoparticles encapsulated with Emodin reverse multidrug resistance of breast cancer via IL-6/JAK2/STAT3 signaling pathway
Honghui Gu, Fansu Meng, Lina Yang et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Aug 2023
112 days before retraction
Compound shougong powder inhibits the malignant phenotype of hepatocellular carcinoma cells by targeting the DNA damage repair pathway
Yongfu Zhu, Jing Xu, Jian Wu et al. (9 authors)
Journal of Pharmacy and Pharmacology
Published: Mar 2023
2 citations
2 citations
256 days before retraction
Research Progress of Traditional Chinese Medicine Monomers in Reversing Multidrug Resistance of Breast Cancer
Shuya Wang, Shuangyu Yang, Xiaojia Yang et al. (6 authors)
The American Journal of Chinese Medicine
Published: Jan 2023
24 citations
24 citations
340 days before retraction
Phytochemical Targeting of Mitochondria for Breast Cancer Chemoprevention, Therapy, and Sensitization
Elizabeth R. M. Zunica, Christopher L. Axelrod, John P. Kirwan
International Journal of Molecular Sciences
Open Access
Published: Nov 2022
7 citations
7 citations
386 days before retraction
Recent advances in the therapeutic potential of emodin for human health
Javad Sharifi‐Rad, Jesús Herrera‐Bravo, Senem Kamiloğlu et al. (14 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Aug 2022
66 citations
66 citations
471 days before retraction
The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers
Qing Zhang, Wenwen Chen, Xue Sun et al. (10 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2022
44 citations
44 citations
705 days before retraction
Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63
Monika Horvat, Martina Avbelj, María Beatriz Durán Alonso et al. (6 authors)
Molecules
Open Access
Published: Nov 2021
19 citations
19 citations
756 days before retraction
The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb—A Summary Update
Monika Stompor
International Journal of Molecular Sciences
Open Access
Published: Sep 2021
93 citations
93 citations
827 days before retraction
Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin
Esra Küpeli Akkol, I. İrem Tatlı, Gökçe Şeker Karatoprak et al. (7 authors)
Cancers
Open Access
Published: May 2021
89 citations
89 citations
920 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #51131
Jun 02, 2021Quick Stats
Total Citations:
13
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025